The uAspire website is currently down. We are working on restoring it and appreciate your patience. If you need immediate support, please email [email protected].

Usona Institute has launched its Phase 3 study, "A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Psilocybin in Adults With Major Depressive …

Dec 15, 2025 · Participants will be randomly assigned to receive a single oral dose of Psilocybin 25 mg, Psilocybin 5 mg, or inactive placebo.

Log in - uAspire. Skip to Main Content. Skip to left navigation.

By simplifying the pathways to federal aid, making college costs transparent to students, and ensuring equitable distribution of resources, uAspire seeks to create more degrees with less debt.

Password Forgot your password?

Use this free calculator to compare your financial aid offers and the estimated total costs of attending different colleges.

Hello fellow mental health professionals in the Seattle area! It has been a while since I posted an update about our currently recruiting clinical… Most people think of habits as physical routines...

Apply for the Crankstart Scholarship, which supports students from San Francisco by providing them with the resources they need to earn their Bachelor’s Degree.

Mar 20, 2024 · Study Details: The uAspire trial is designed to evaluate the efficacy and safety of psilocybin 25 mg as a treatment for MDD that is administered, with psychosocial support, to adults …